IBDEI1A3 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22647,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,22648,0)
 ;;=131.02^^125^1395^57
 ;;^UTILITY(U,$J,358.3,22648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22648,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,22648,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,22648,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,22649,0)
 ;;=597.80^^125^1395^55
 ;;^UTILITY(U,$J,358.3,22649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22649,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,22649,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,22649,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,22650,0)
 ;;=788.41^^125^1395^58
 ;;^UTILITY(U,$J,358.3,22650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22650,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,22650,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,22650,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,22651,0)
 ;;=788.31^^125^1395^62
 ;;^UTILITY(U,$J,358.3,22651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22651,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,22651,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,22651,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,22652,0)
 ;;=788.20^^125^1395^63
 ;;^UTILITY(U,$J,358.3,22652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22652,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,22652,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,22652,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,22653,0)
 ;;=112.2^^125^1395^66
 ;;^UTILITY(U,$J,358.3,22653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22653,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,22653,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,22653,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,22654,0)
 ;;=600.01^^125^1395^5
 ;;^UTILITY(U,$J,358.3,22654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22654,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,22654,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,22654,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,22655,0)
 ;;=600.10^^125^1395^40
 ;;^UTILITY(U,$J,358.3,22655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22655,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,22655,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,22655,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,22656,0)
 ;;=585.9^^125^1395^8
 ;;^UTILITY(U,$J,358.3,22656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22656,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,22656,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,22656,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,22657,0)
 ;;=788.64^^125^1395^59
 ;;^UTILITY(U,$J,358.3,22657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22657,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,22657,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,22657,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,22658,0)
 ;;=788.65^^125^1395^52
 ;;^UTILITY(U,$J,358.3,22658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22658,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,22658,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,22658,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,22659,0)
 ;;=600.00^^125^1395^4
 ;;^UTILITY(U,$J,358.3,22659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22659,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,22659,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,22659,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,22660,0)
 ;;=599.70^^125^1395^20
 ;;^UTILITY(U,$J,358.3,22660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22660,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,22660,1,5,0)
 ;;=5^Hematuria
 ;;^UTILITY(U,$J,358.3,22660,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,22661,0)
 ;;=599.71^^125^1395^21
 ;;^UTILITY(U,$J,358.3,22661,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1A3
